Tehran Jarah Novin Med. Eng. Co.

Tehran Jarah Novin Med. Eng. Co. is a trading Medical company with leading role in Iranian market of Reproductive Health and Surgical products at different fields such as MIS, Bariatric, Diabetes, Colorectal, Neuro, ENT, GYN, URO, and etc. TJN was founded in 2005 as daughter company of Flip Flop Eng. Co., an old established medical corporation with over 40 years business in healthcare market. In 2014, TJN was acquired by great Ruyan Commercial Holding, as a well reputed pharmaceutical trading company, which has been active since 1947, located in Persian Gulf region. We are privileged to be a real customer driven company. Our vision is about providing best quality of service to meet customers’ satisfaction. Today TJN represents advanced therapies and quality products from top brands like: Medtronic, Cook Medical, Integra Life Science, Sapimed and … TJN is designed for success of medical centers, whenever looking for a better patients’ outcome. Our structure and working process fulfill domestic and international medical regulations. It also complies with OFAC rules aiming a long-term partnership with our suppliers. Our leadership team is conducting different sections of TJN including Finance, Accounting, Dedicated Sales and Marketing departments, Technical support, Customer care, Commercial & Regulatory Administration, Warehouse, Logistic, IT and … align with our mission. Our mission is to promote level of therapies in Iranian hospitals through supplying new technologies, and to serve HCPs and patients under the most challenging circumstances.

synergen technology labs (pvt) ltd

We are a passionate team of engineers and innovators who believe in a deeply interconnected world powered by the Internet of Things to improve the quality of life across the globe. We engage in Health and Wellness aspects of IoT products and solutions, and partner with our clients to co-innovate from concept to product launch.

nice neotech medical systems pvt. ltd.

nice Neotech, NICE stands for Neonatal Intensive Care Equipments provides health care equipments to the hospital needs, Neonatal care equipment, Neonatal Intensive Care Equipments also have all types of baby incubator and Anaesthesia machine.

ELMED Medical Systems

ELMED was established in 1991 in Ankara as a manufacturer of ESWL Systems in Turkey. The leader of the market, ELMED carries out production, domestic sales and export activities in the field of urology and offers lithotripsy devices with innovative, effective and advanced technology to the medical world. ELMED, which has more than 900 installations in more than 60 countries, has obtained CE certificate for its entire product range by fulfilling the high safety and performance requirements within the scope of the European Medical Device Directive. ELMED, Türkiye'nin İLK Böbrek Taşı Kırma Cihazı üreticisi olarak 1991 yılında Ostim'de kurulmuş, Türkiye'nin ilk yüksek teknolojili tıbbi cihaz üreticisi firmalarından biridir.

Qynapse

The future of neuroimaging analysis is here and Qynapse is leading the way. For clinicians on the front lines, for patients and their families, for payers, and for pharma – we offer peace of mind by providing results you can trust. Headquartered in France, in the United States and in Canada, the Qynapse team, with our world-renowned team of scientific and clinical partners, is wholly dedicated to aspiring to bring the entire neuroscience community and their patients the clearest, most accurate and reliable predictors and objective measures of devastating CNS disorders such as Alzheimer's disease, multiple sclerosis and Parkinson’s disease. We are constantly evolving, refining and testing our FDA-cleared and CE-marked neuroimaging software platform, QyScore®, which is powered by proprietary Artificial Intelligence, to provide physicians, pharma researchers and payers a reliable layer of precision when reading an MRI scan. QyPredict®, our predictive research-use-only platform powered by machine learning algorithms, is being designed to transform what we know about CNS disease trajectory, with the potential to dramatically increase the likelihood of a successful clinical trial. Together, we are moving forward to a brighter and more accurate future of diagnosis and treatment for central nervous system diseases.